Management of Interruptions in Radiotherapy Treatments: Adaptive Implementation in High Workload Sites

Overview

Journal Rep Pract Oncol Radiother

Specialty Oncology

Date 2019 Mar 13

PMID 30858768

Authors

Gustavo Pozo

Maria Angeles Perez-Escutia

Ana Ruiz

Alejandro Ferrando

Ana Milanes

Eduardo Cabello

Raul Diaz

Alejandro Prado

Jose Fermin Perez-Regadera

Affiliations

Soon will be listed here.

Abstract

Owing to predictable or unpredictable causes, interruptions may arise during therapy. On average, the extension of fractionated radiotherapy treatments is prone to be delayed by several weeks and interruptions can come up extending overall treatment time (OTT). Clonogenic cells of aggressive tumors might benefit from this situation, modifying local control (LC). Preserving treatment quality in radiotherapy is an essential issue for the treatment outcome, and our institution is increasingly concerned about this line of work. Establishing some objective criteria to schedule patients that have suffered interruptions along their treatments is of capital importance and not a trivial issue. Publications strongly encourage departments to minimize the effect of lag periods during treatments. Therefore, in July 2017, our facility implemented the so called 'Protocol to Manage Interruptions in Radiotherapy', based on a scoring system for patient categorization that considers not only histology but also associated comorbidity and sequence of the therapy.

References

Bentzen S, Saunders M, Dische S . Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. Radiother Oncol. 2000; 53(3):219-26. DOI: 10.1016/s0167-8140(99)00151-6. View

Bentzen S, Saunders M, Dische S, Bond S . Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol. 2001; 60(2):123-35. DOI: 10.1016/s0167-8140(01)00358-9. View

Tarnawski R, Fowler J, Skladowski K, Swierniak A, Suwinski R, Maciejewski B . How fast is repopulation of tumor cells during the treatment gap?. Int J Radiat Oncol Biol Phys. 2002; 54(1):229-36. DOI: 10.1016/s0360-3016(02)02936-x. View

Dale R, Hendry J, Jones B, Robertson A, Deehan C, Sinclair J . Practical methods for compensating for missed treatment days in radiotherapy, with particular reference to head and neck schedules. Clin Oncol (R Coll Radiol). 2003; 14(5):382-93. DOI: 10.1053/clon.2002.0111. View

Piccirillo J, Tierney R, Costas I, Grove L, Spitznagel Jr E . Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004; 291(20):2441-7. DOI: 10.1001/jama.291.20.2441. View

Gonzalez San Segundo C, Calvo Manuel F, Santos Miranda J . [Delays and treatment interruptions: difficulties in administering radiotherapy in an ideal time-period]. Clin Transl Oncol. 2005; 7(2):47-54. DOI: 10.1007/BF02710009. View

Bese N, Hendry J, Jeremic B . Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys. 2007; 68(3):654-61. DOI: 10.1016/j.ijrobp.2007.03.010. View

James N, Williams M, Summers E, Jones K, Cottier B . The management of interruptions to radiotherapy in head and neck cancer: an audit of the effectiveness of national guidelines. Clin Oncol (R Coll Radiol). 2008; 20(8):599-605. DOI: 10.1016/j.clon.2008.05.003. View

Macia I Garau M, Sole Monne J, Cambra Seres M, Monfa Binefa C, Peraire Llopis M . Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays. Clin Transl Oncol. 2009; 11(5):302-11. DOI: 10.1007/s12094-009-0358-2. View

10.

Vogelius I, Bentzen S . Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news?. Int J Radiat Oncol Biol Phys. 2012; 85(1):89-94. PMC: 3556929. DOI: 10.1016/j.ijrobp.2012.03.004. View

11.

Koh T, Thng C, Hartono S, Dominguez L, Lim T, Huynh H . Assessment of tumor necrotic fraction by dynamic contrast-enhanced MRI: a preclinical study of human tumor xenografts with histopathologic correlation. NMR Biomed. 2014; 27(4):486-94. DOI: 10.1002/nbm.3090. View

12.

Emaminejad N, Qian W, Guan Y, Tan M, Qiu Y, Liu H . Fusion of Quantitative Image and Genomic Biomarkers to Improve Prognosis Assessment of Early Stage Lung Cancer Patients. IEEE Trans Biomed Eng. 2015; 63(5):1034-1043. DOI: 10.1109/TBME.2015.2477688. View

13.

Gonzalez Ferreira J, Jaen Olasolo J, Azinovic I, Jeremic B . Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature. Rep Pract Oncol Radiother. 2015; 20(5):328-39. PMC: 4597087. DOI: 10.1016/j.rpor.2015.05.010. View

14.

Gillies R, Kinahan P, Hricak H . Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2015; 278(2):563-77. PMC: 4734157. DOI: 10.1148/radiol.2015151169. View

15.

Garcia-Figueiras R, Baleato-Gonzalez S, Padhani A, Luna-Alcala A, Marhuenda A, Vilanova J . Advanced Imaging Techniques in Evaluation of Colorectal Cancer. Radiographics. 2018; 38(3):740-765. DOI: 10.1148/rg.2018170044. View

16.

Sanduleanu S, Woodruff H, de Jong E, van Timmeren J, Jochems A, Dubois L . Tracking tumor biology with radiomics: A systematic review utilizing a radiomics quality score. Radiother Oncol. 2018; 127(3):349-360. DOI: 10.1016/j.radonc.2018.03.033. View

17.

Withers H, Taylor J, Maciejewski B . The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988; 27(2):131-46. DOI: 10.3109/02841868809090333. View

18.

Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

19.

Skladowski K, Law M, Maciejewski B, STEEL G . Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration. Radiother Oncol. 1994; 30(2):109-20. DOI: 10.1016/0167-8140(94)90039-6. View

20.

Hendry J, Bentzen S, Dale R, Fowler J, Wheldon T, Jones B . A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol (R Coll Radiol). 1996; 8(5):297-307. DOI: 10.1016/s0936-6555(05)80715-0. View